z-logo
open-access-imgOpen Access
Airway Pressure Release Ventilation: A Review of the Evidence, Theoretical Benefits, and Alternative Titration Strategies
Author(s) -
Andrew Fredericks,
Matthew P. Bunker,
Louise A. Gliga,
Callie Ebeling,
Jenny Ringqvist,
Hooman Heravi,
James Manley,
Jason Valladares,
Bryan T. Romito
Publication year - 2020
Publication title -
clinical medicine insights circulatory respiratory and pulmonary medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.429
H-Index - 17
ISSN - 1179-5484
DOI - 10.1177/1179548420903297
Subject(s) - intensive care medicine , ventilation (architecture) , observational study , medicine , randomized controlled trial , anesthesia , surgery , mechanical engineering , engineering
Objective: To review the theoretical benefits of airway pressure release ventilation (APRV), summarize the evidence for its use in clinical practice, and discuss different titration strategies. Data Source: Published randomized controlled trials in humans, observational human studies, animal studies, review articles, ventilator textbooks, and editorials. Data Summary: Airway pressure release ventilation optimizes alveolar recruitment, reduces airway pressures, allows for spontaneous breathing, and offers many hemodynamic benefits. Despite these physiologic advantages, there are inconsistent data to support the use of APRV over other modes of ventilation. There is considerable heterogeneity in the application of APRV among providers and a shortage of information describing initiation and titration strategies. To date, no direct comparison studies of APRV strategies have been performed. This review describes 2 common management approaches that bedside providers can use to optimally tailor APRV to their patients. Conclusion: Airway pressure release ventilation remains a form of mechanical ventilation primarily used for refractory hypoxemia. It offers unique physiological advantages over other ventilatory modes, and providers must be familiar with different titration methods. Given its inconsistent outcome data and heterogeneous use in practice, future trials should directly compare APRV strategies to determine the optimal management approach.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom